Detalhe da pesquisa
1.
Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior.
Mol Pharm
; 16(8): 3524-3533, 2019 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31268724
2.
Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model.
Blood
; 125(13): 2111-9, 2015 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25628467
3.
Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b.
BMC Cancer
; 17(1): 303, 2017 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28464843
4.
Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide Immunoconjugates.
Bioconjug Chem
; 27(3): 688-97, 2016 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26791409
5.
Anti-CD45 radioimmunotherapy using (211)At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model.
Blood
; 121(18): 3759-67, 2013 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23471305
6.
In vitro and in vivo evaluation of a tetrazine-conjugated poly-L-lysine effector molecule labeled with astatine-211.
EJNMMI Radiopharm Chem
; 9(1): 43, 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775973
7.
A Novel Method for Real-Time Quantification of Radioligand Binding to Living Tumor Cells In Vitro.
Cancer Biother Radiopharm
; 39(1): 75-81, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265676
8.
Role of CaMKII and ROS in rapid pacing-induced apoptosis.
J Mol Cell Cardiol
; 63: 135-45, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23911439
9.
Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model.
Blood
; 118(3): 703-11, 2011 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21613259
10.
Pretargeted Alpha Therapy of Disseminated Cancer Combining Click Chemistry and Astatine-211.
Pharmaceuticals (Basel)
; 16(4)2023 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37111352
11.
Estimating the Risk for Secondary Cancer After Targeted α-Therapy with 211At Intraperitoneal Radioimmunotherapy.
J Nucl Med
; 64(1): 165-172, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798559
12.
Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease.
Blood
; 116(20): 4231-9, 2010 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-20702781
13.
Covalent core-radiolabeling of polymeric micelles with 125I/211At for theranostic radiotherapy.
Nanotheranostics
; 6(4): 388-399, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35912139
14.
Astatine-211 based radionuclide therapy: Current clinical trial landscape.
Front Med (Lausanne)
; 9: 1076210, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36687417
15.
Modeling bystander effects that cause growth delay of breast cancer xenografts in bone marrow of mice treated with radium-223.
Int J Radiat Biol
; 97(9): 1217-1228, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34232830
16.
Radium-223-Induced Bystander Effects Cause DNA Damage and Apoptosis in Disseminated Tumor Cells in Bone Marrow.
Mol Cancer Res
; 19(10): 1739-1750, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34039648
17.
Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer.
Transl Oncol
; 14(1): 100873, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32987283
18.
Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure.
Cancer Biother Radiopharm
; 35(6): 425-436, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32077749
19.
Dose-Dependent Growth Delay of Breast Cancer Xenografts in the Bone Marrow of Mice Treated with 223Ra: The Role of Bystander Effects and Their Potential for Therapy.
J Nucl Med
; 61(1): 89-95, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31519805
20.
Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors.
EJNMMI Res
; 10(1): 10, 2020 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32048062